Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-01-11 @ 9:13 PM
Study NCT ID:
NCT00296205
Status:
WITHDRAWN
Last Update Posted:
2009-07-22
First Post:
2006-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Sponsor:
Stony Brook University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-02
Completion Date Type:
ESTIMATED
First Submit Date:
2006-02-23
First Submit QC Date:
None
Study First Post Date:
2006-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-07-21
Last Update Post Date:
2009-07-22
Last Update Post Date Type:
ESTIMATED